Rivastigmine modifies the a-secretase pathway and potentially early Alzheimer's disease.

Rivastigmine modifies the a-secretase pathway and potentially early Alzheimer's disease. Transl Psychiatry. 2020 02 03; 10(1):47.

View in: PubMed